These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1436341)

  • 1. Peritoneal hemosiderosis in pediatric patients with nephrogenic ascites.
    Beşbaş N; Söylemezoğlu O; Saatçi U; Bakkaloğlu A; Arslan S; Göğüş S; Topaloğlu R
    Nephron; 1992; 62(3):292-5. PubMed ID: 1436341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and course of nephrogenic ascites.
    Mauk PM; Schwartz JT; Lowe JE; Smith JL; Graham DY
    Arch Intern Med; 1988 Jul; 148(7):1577-9. PubMed ID: 2968075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of a patient with end-stage renal disease, severe iron overload and ascites by weekly phlebotomy combined with recombinant human erythropoietin.
    Nomura S; Osawa G; Karai M
    Nephron; 1990; 55(2):210-3. PubMed ID: 2362636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is nephrogenic ascites related to secondary hyperparathyroidism?
    Nasr EM; Joubran NI
    Am J Kidney Dis; 2001 Feb; 37(2):E16. PubMed ID: 11157402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrogenic ascites: a poorly understood syndrome.
    Hammond TC; Takiyyuddin MA
    J Am Soc Nephrol; 1994 Nov; 5(5):1173-7. PubMed ID: 7873726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrogenic ascites. Analysis of 16 cases and review of the literature.
    Han SH; Reynolds TB; Fong TL
    Medicine (Baltimore); 1998 Jul; 77(4):233-45. PubMed ID: 9715728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrogenic ascites. Case report and review of the literature.
    Cintin C; Joffe P
    Scand J Urol Nephrol; 1994 Sep; 28(3):311-4. PubMed ID: 7817179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of refractory ascites during amiodarone therapy in a hemodialysis patient with nephrogenic and cardiogenic ascites.
    Wang JY; Hwang B; Lin YF; Chen JD
    Ren Fail; 2012; 34(8):1033-6. PubMed ID: 22880809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Deferoxamine B treatment of hemosiderosis in the anephric patient undergoing hemodialysis].
    Ceriati F; Cavicchioni C; Marino IR; Pomponi M
    Chir Patol Sper; 1981 Feb; 29(1):14-9. PubMed ID: 7344858
    [No Abstract]   [Full Text] [Related]  

  • 10. Ascites in a patient undergoing maintenance hemodialysis.
    Kes P; Ratković-Gusić I; Sefer S
    Acta Med Croatica; 1997; 51(1):57-61. PubMed ID: 9115105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chylous nephrogenic ascites in a hemodialysis patient.
    Mabood Khalil MA; Haji Jukmin MK; Chong VH; Tan J
    Saudi J Kidney Dis Transpl; 2020; 31(3):687-692. PubMed ID: 32655055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAPD for treatment of ESRD patients with ascites secondary to liver cirrhosis.
    Bajo MA; Selgas R; Jimenez C; Del Peso G; Fernandez-Reyes MJ; Dapena F; De Alvaro F
    Adv Perit Dial; 1994; 10():73-6. PubMed ID: 7999868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron overload, but not treatment with desferrioxamine favours the development of septicemia in patients on maintenance hemodialysis.
    Seifert A; von Herrath D; Schaefer K
    Q J Med; 1987 Dec; 65(248):1015-24. PubMed ID: 3455553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
    Simon P; Bonn F; Guezennec M; Tanquerel T; Ksang
    Nephrologie; 1981; 2(4):165-70. PubMed ID: 7329501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ascites in Patients on Maintenance Hemodialysis: Causes, Characteristics and Predicting Factors.
    Tasneem AA; Khan AA; Abbas Z; Luck NH; Hassan SM
    J Coll Physicians Surg Pak; 2016 May; 26(5):413-9. PubMed ID: 27225149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intractable ascites during maintenance hemodialysis.
    Uy A; Shalhoub RJ; O'Connell JM; Matthews MJ; Higgins GA
    Med Ann Dist Columbia; 1973 Jun; 42(6):277-9. PubMed ID: 4514577
    [No Abstract]   [Full Text] [Related]  

  • 18. [Nephrogenic ascites: a poorly understood syndrome: a case report].
    Hellara O; Hammami A; Ben Chaabène N; Aloui S; Melki W; Loghmari H; Ben Mansour W; Safer L; Zakhama A; Noomen F; Bdioui F; Saffar H
    Tunis Med; 2013 Nov; 91(11):671-3. PubMed ID: 24343494
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nephrogenic ascites. A case report].
    Elloumi H; Arfaoui D; Zayane A; Ajmi S
    Ann Med Interne (Paris); 2002 Nov; 153(7):478-80. PubMed ID: 12598834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of peritoneal-extracorporeal shunting for refractory hemodialysis ascites.
    Hida M; Takamiya T; Iida T; Kitajima N; Hiraga S; Satoh T
    Tokai J Exp Clin Med; 1987 May; 12(2):79-81. PubMed ID: 3449987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.